ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.03
0.49%
US Tech 100
21,422.25
1.37%
S&P 500
6,115.07
1.04%
US Dollar vs CAD
1.41935
0.00%
Bitcoin
96,597.79
-0.02%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rapport Therapeutics Inc (RAPP)

  7. Rapport Therapeutics Inc (RAPP) News

RAPP

Rapport Therapeutics (RAPP)

Rapport Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RAPP
DateTimeSourceHeadlineSymbolCompany
02/04/20254:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
02/04/20254:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
01/10/20255:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPPRapport Therapeutics Inc
01/09/20258:12AMGlobeNewswire Inc.CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS DisordersNASDAQ:RAPPRapport Therapeutics Inc
01/09/20256:00AMGlobeNewswire Inc.Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS DisordersNASDAQ:RAPPRapport Therapeutics Inc
12/06/202411:01AMGlobeNewswire Inc.Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical SeizuresNASDAQ:RAPPRapport Therapeutics Inc
11/14/20246:00AMGlobeNewswire Inc.Rapport Therapeutics to Present Data at American Epilepsy Society Annual MeetingNASDAQ:RAPPRapport Therapeutics Inc
11/07/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
11/07/20245:27PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
11/07/20246:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAPPRapport Therapeutics Inc
11/07/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPPRapport Therapeutics Inc
11/07/20246:00AMGlobeNewswire Inc.Rapport Therapeutics Reports Third Quarter Financials and Provides Business UpdateNASDAQ:RAPPRapport Therapeutics Inc
11/04/20246:00AMGlobeNewswire Inc.Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in NovemberNASDAQ:RAPPRapport Therapeutics Inc
09/05/20246:00AMGlobeNewswire Inc.Rapport Therapeutics to Present at Upcoming Epilepsy Medical ConferencesNASDAQ:RAPPRapport Therapeutics Inc
08/29/20246:00AMGlobeNewswire Inc.Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry SummitNASDAQ:RAPPRapport Therapeutics Inc
08/08/20246:00AMGlobeNewswire Inc.Rapport Therapeutics Reports Second Quarter Financials and Provides Business UpdateNASDAQ:RAPPRapport Therapeutics Inc
07/29/20246:00AMGlobeNewswire Inc.Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on PainNASDAQ:RAPPRapport Therapeutics Inc
06/12/20243:01PMGlobeNewswire Inc.Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private PlacementNASDAQ:RAPPRapport Therapeutics Inc
06/10/20246:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
06/10/20246:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
06/10/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPPRapport Therapeutics Inc
06/06/20245:54PMGlobeNewswire Inc.Rapport Therapeutics Announces Pricing of Initial Public OfferingNASDAQ:RAPPRapport Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RAPP

Your Recent History

USOTC
IDVV
International Endeavors (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
AZRH
Azure (PK)
NASDAQ
MGOL
MGO Global
USOTC
GVSI
Good Vibrations Shoes (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
ASII
Accredited Solutions (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
TGLO
TheGlobe com (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NYSE
AMC
AMC Entertainment
USOTC
SPZI
Spooz (PK)
NASDAQ
ENTA
Enanta Pharmaceuticals
USOTC
HIRU
Hiru (PK)
USOTC
ADIA
Adia Nutrition (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads